JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4901
Star Holdings Shares of Beneficial Interest
STHO
$102M
| $445K | ﹤0.01% |
45,688
+23,075
| +102% | +$269K |
2023 Q1
7 quarters
|
|
4902
Enliven Therapeutics
ELVN
$3.44B
| $444K | ﹤0.01% |
19,745
-1,062
| -5% | -$27.5K |
2023 Q1
7 quarters
|
|
4903
PUT
CoStar Group
CSGP
$11.1B
| $444K | ﹤0.01% |
+6,200
| New | +$468K |
2024 Q4
0 quarters
|
|
4904
Alta Equipment Group
ALTG
$212M
| $443K | ﹤0.01% |
67,722
+16,304
| +32% | +$114K |
2020 Q2
18 quarters
|
|
|
HTT
4905
High Templar Tech Ltd
HTT
$359M
| $442K | ﹤0.01% |
+156,844
| New | +$395K |
2024 Q4
0 quarters
|
|
4906
CALL
Nice
NICE
$6.67B
| $442K | ﹤0.01% |
2,600
-200
| -7% | -$35.7K |
2023 Q4
4 quarters
|
|
4907
AudioCodes
AUDC
$268M
| $441K | ﹤0.01% |
45,299
-58,738
| -56% | -$541K |
2018 Q3
25 quarters
|
|
|
SVCO
4908
Silvaco Group
SVCO
$310M
| $441K | ﹤0.01% |
54,583
-54,866
| -50% | -$457K |
2024 Q3
1 quarter
|
|
4909
AB Tax-Aware Long Municipal ETF
TAFL
$60.5M
| $441K | ﹤0.01% |
17,505
-9,918
| -36% | -$253K |
2024 Q1
3 quarters
|
|
4910
Fidelity International High Dividend ETF
FIDI
$378M
| $440K | ﹤0.01% |
22,573
+6,024
| +36% | +$123K |
2024 Q2
2 quarters
|
|
4911
Tejon Ranch
TRC
$443M
| $440K | ﹤0.01% |
27,666
+18,149
| +191% | +$293K |
2015 Q4
36 quarters
|
|
4912
Fresenius Medical Care
FMS
$11.8B
| $440K | ﹤0.01% |
19,426
+9,524
| +96% | +$207K |
2013 Q2
46 quarters
|
|
4913
iShares MSCI Qatar ETF
QAT
$56.2M
| $439K | ﹤0.01% |
24,472
-1,822
| -7% | -$33.2K |
2022 Q1
11 quarters
|
|
4914
Anavex Life Sciences
AVXL
$169M
| $438K | ﹤0.01% |
40,823
-1,742
| -4% | -$13.4K |
2019 Q2
22 quarters
|
|
4915
Information Services Group
III
$276M
| $438K | ﹤0.01% |
131,103
-166,627
| -56% | -$557K |
2017 Q4
28 quarters
|
|
4916
ProShares Short 7-10 Year Treasury
TBX
$20.9M
| $437K | ﹤0.01% |
15,037
+5,343
| +55% | +$156K |
2023 Q3
5 quarters
|
|
|
BZUN
4917
Baozun
BZUN
$183M
| $436K | ﹤0.01% |
160,178
-1,422
| -0.9% | -$4.3K |
2019 Q4
20 quarters
|
|
4918
Portillo's
PTLO
$255M
| $434K | ﹤0.01% |
46,179
-735
| -2% | -$8.41K |
2021 Q4
12 quarters
|
|
4919
PUT
Teva Pharmaceutical Industries Limited
TEVA
$46.1B
| $432K | ﹤0.01% |
19,600
-655,400
| -97% | -$11.9M |
2024 Q3
1 quarter
|
|
4920
CALL
Wave Life Sciences
WVE
$745M
| $432K | ﹤0.01% |
+34,900
| New | +$466K |
2024 Q4
0 quarters
|
|
4921
Acacia Research
ACTG
$424M
| $429K | ﹤0.01% |
98,841
+71,153
| +257% | +$322K |
2015 Q4
36 quarters
|
|
|
HLVX
4922
DELISTED
HilleVax
HLVX
| $429K | ﹤0.01% |
207,151
+193,124
| +1,377% | +$363K |
2022 Q2
10 quarters
|
|
4923
Pioneer Bancorp
PBFS
$430M
| $427K | ﹤0.01% |
37,024
+21,904
| +145% | +$250K |
2019 Q3
21 quarters
|
|
|
STRS
4924
DELISTED
STRATUS PPTYS INC
STRS
| $425K | ﹤0.01% |
20,460
+10,857
| +113% | +$261K |
2016 Q4
32 quarters
|
|
4925
Hertz
HTZ
$627M
| $424K | ﹤0.01% |
115,754
-50,791
| -30% | -$184K |
2022 Q1
11 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.